Workshop INTA on ACTA

From La Quadrature du Net
Revision as of 20:11, 20 February 2012 by Meli melo (talk | contribs) (Location)
Jump to navigationJump to search


On March 1st, 2012, the European Parliament's "INTA" committee holds a public workshop on ACTA.
This page give all the information on this meeting. We invite you to come, in order to ask the members of the European Parliament and of the European Commission about the many points making ACTA an illegitimate agreement, that must be rejected.


Practical information

Location

European Parliament
Brussels
Paul-Henri Spaak Building

WARNING ! Room has changed:
Room JAN 4Q2

Time

Thursday, 1 March 2012
From 15.00 to 18.30

How to attend

Download and fill the registration form, then send it to poldep-expo@europarl.europa.eu
You'll be given a badge at your arrival at the European Parliament
Don't forget your ID !

WARNING : the registration deadline is on Tuesday, 21 February 2012

Download the registration form

Programme

  • 15:00 : Welcome and introduction to the workshop by INTA Chairman Prof. Vital MOREIRA
  • 15:15: A comprehensive assessment of the “Anti-Counterfeiting Trade Agreement” (ACTA) and the EU IPR protection and enforcement-related trade policies.

Speakers: Mr Karel DE GUCHT (EU Commissioner for Trade), Dr Michael GEIST (University of Ottawa), Prof. Christophe GEIGER (University of Strasbourg)

  • 16.15: Presentation of the European Parliament’s External Study entitled “The Anti-Counterfeiting Trade Agreement” (Policy Department, 2011)

Speakers: Prof. Anselm Kamperman SANDERS (Maastricht University) Prof. Dalindyebo SHABALALA (Maastricht University)
The presentation will be followed by comments from the European Commission represented by Mr Pedro VELASCO MARTINS

  • 17.15: Specific aspects of ACTA

The EU acquis and ACTA: Are civil liberties under threat? - What will be the likely impact of ACTA on EU Member States’ national legislation on IPR enforcement?
Speakers: Dr Olivier VRINS (ALTIUS Lawyers), Mr Rupert SCHLEGELMILCH (Director, European Commission, DG Trade) or Mr Anders JESSEN (Head of Unit, European Commission DG TRADE)
Is ACTA likely to restrict access to medicines in developing countries? Is ACTA a potential danger for trade in generic drugs?
Speakers: Dr Meir PUGATCH (University of Haifa), Mr Rupert SCHLEGELMILCH (Director, European Commission, DG Trade) or Mr Anders JESSEN (Head of Unit, European Commission DG TRADE)

  • 18.15 Concluding remarks by INTA rapporteur
  • 18.25 Closure of the workshop by INTA Chairman Prof. Vital MOREIRA